[144] Power Solutions International, Inc. SEC Filing

Rhea-AI Filing Summary

The filing is a Form 144 notice for Power Solutions International, Inc. (PSIX) reporting a proposed sale of 1,500 common shares through Morgan Stanley Smith Barney LLC. The shares were acquired on 07/10/2024 upon restricted stock vesting under a registered plan and were paid as compensation. The filer lists an approximate sale date of 09/11/2025 and an aggregate market value at the time of notice of $141,000.00. The issuer's total shares outstanding is reported as 23,029,846. The filer certifies they are not aware of any undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for vested restricted stock; transaction appears procedural without disclosed material impact.

The Form 144 shows an individual proposing to sell 1,500 shares acquired through restricted stock vesting and paid as compensation. The sale is to be executed through Morgan Stanley Smith Barney. The filing includes the filers representation that no undisclosed material adverse information exists. Based solely on the disclosed facts, this is a standard required notice for an insider disposition and does not by itself indicate a change in company fundamentals.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 procedural requirements; no governance red flags are shown in the notice.

The document provides key Rule 144 elements: acquisition date, nature of acquisition (restricted stock vesting), amount, broker, proposed sale date, and outstanding shares. The signer affirms absence of undisclosed material information and warns about criminal penalties for misstatements. The filing is consistent with routine officer/insider compliance and trading-plan disclosure norms as presented.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1500	141000.00	23029846	09/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/10/2024	Restricted stock vesting under a registered plan	Issuer			1500	07/10/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PSIX Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 1,500 common shares through Morgan Stanley Smith Barney with an aggregate market value of $141,000 and an approximate sale date of 09/11/2025.

How were the shares acquired that are being sold under Form 144 (PSIX)?

The shares were acquired on 07/10/2024 as restricted stock vesting under a registered plan and the payment was for compensation.

How many PSIX shares outstanding does the filing report?

The filing reports 23,029,846 shares outstanding.

Does the Form 144 state whether there is any undisclosed material information?

Yes. By signing the notice the person represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.

Who is the broker named for the proposed PSIX sale?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services located at 1 New York Plaza, 8th Floor, New York, NY.